Evidence map›Paper›PMID 16738044›Full record

ReviewThorax2006

COPD exacerbations.5: management.

R Rodríguez-Roisin

Abstract readReview
In one paragraph

Review in Thorax, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Tiotropium Attenuates Virus-Induced Pulmonary Inflammation in Cigarette Smoke-Exposed Mice.The Journal of pharmacology and experimental therapeutics · 2016
    Article
  10. Review
  11. Review
  12. A systematic review and meta-analysis of herbal medicine on chronic obstructive pulmonary diseases.Evidence-based complementary and alternative medicine : eCAM · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Non-invasive ventilation in exacerbations of COPD.International journal of chronic obstructive pulmonary disease · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

R Rodríguez-RoisinServei de Pneumologia, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. rororo@clinic.ub.es

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A review of the most relevant evidence based therapeutic options currently available for the management of exacerbations of COPD.

Indexed as

Acute DiseaseAdrenal Cortex HormonesAnti-Bacterial AgentsBronchodilator AgentsEvidence-Based MedicineHospitalizationHumansOxygen Inhalation TherapyPulmonary Disease, Chronic ObstructiveRespiratory Function TestsAdrenal Cortex HormonesAnti-Bacterial AgentsBronchodilator Agents

Identifiers

PMID16738044
PMCPMC2111219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.